{
  "info": {
    "company_name": "Repligen Corporation",
    "company_url": "https://www.responsibilityreports.com/Company/repligen-corporation",
    "ticker_name": "RGEN",
    "exchange": "NASDAQ",
    "industry": "Medical Instruments & Supplies",
    "sector": "Healthcare",
    "about_company": "Repligen Corporation (NASDAQ:RGEN) is a bioprocessing company focused on the development, manufacture and commercialization of highly innovative products used to improve the interconnected phases of the biological drug manufacturing process. Repligen's portfolio includes protein products (Protein A affinity ligands, cell culture growth factors), chromatography products (OPUS\u00ae pre-packed\u2026More",
    "num_employees": "1001-5000 Employees",
    "location": "Based in Waltham, Massachusetts"
  },
  "reports": [
    {
      "pdf_url": "https://www.responsibilityreports.com/HostedData/ResponsibilityReports/PDF/NASDAQ_RGEN_2020.pdf",
      "report_name": "NASDAQ_RGEN_2020"
    }
  ]
}